We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bemiparina en obstetricia crítica.
- Authors
Briones-Vega, Carlos; Viruez-Soto, José Antonio; Vallejo-Narváez, Carla María; Nieto-Anaya, Nabile Montserrat; Briones-Garduño, Jesús Carlos; Díaz-de León-Ponce, Manuel Antonio
- Abstract
Background: Thromboembolism persists as a main cause of maternal mortality, even in developed countries. Bemiparin is a second generation low molecular weight heparin, with the lowest molecular weight, longest half life and highest activity anti-FXa/anti-FIIa ratio (8:1). The objective is describe the experience in thromboprofilaxis with bemiparin in the Critical Care Obstetrics Unit in Hospital General de México «Dr. Eduardo Liceaga» during period may 2-june 2 of 2014. Methods: All the patients (n = 25) received 3,500 UI of bemiparin per day, as non alternant-TED stockings. Results: The Wells and Geneva scores, at the admission as outcome dismiss thromboembolism, there were no deaths, nor adverse events associated to the administration of bemiparin. Conclussions: The pharmacological profile of bemiparin, suggests it as the first line drug in thromboprofilaxis in Critical Care Obstetrics patients.
- Subjects
THROMBOEMBOLISM; MATERNAL mortality; HEPARIN; OBSTETRICAL research; CRITICAL care medicine
- Publication
Revista Mexicana de Anestesiología, 2014, Vol 37, Issue 4, p266
- ISSN
0484-7903
- Publication type
Article